The table below shows a list of The Lymphoma Group's current clinical trials open/due to open for recruitment for Diffuse large B-cell lymphoma patients.
If you would like to know how to access our trials please click here
Trial Name |
Description |
Click the link for more information (external page) |
GEN3013 |
Phase 1/2 study using antibody GEN3013 to target CD20- expressing cells in patients with B cell non Hodgkin lymphoma
|
|
BI 1206 CRUK CD32b |
Phase 1/2a study looking at blocking the CD32b protein with the antibody BI 1206.
|
|
JCAR017 |
Phase 2 study determining efficacy and safety of JCAR017 Suitable for patients with lymphoma which has come back after previous treatment
|
|
LYMRIT 37 05 |
Phase 1 study of the antibody Betalutin® which targets the CD37 antigen.
|
|
MaPLe |
Non-medicinal (observational) study involving molecular profiling on patients with suspected or confirmed DLBCL or grade 3b follicular lymphoma
|
|
RiVa |
Phase 2 trial testing the combination of rituximab and varlilumab in people with high grade and low grade lymphomas
|
|
GO29781 |
A phase 1/1b trial testing mosunetuzumab, on its own or with atezolizumab
|
*Please note, we update this page fortnightly
With special thanks to the following: